TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CLYM

Climb Bio Inc

Healthcare · Biotechnology

12.50$ -11.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CLYM
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– – – – – – –
– – – – – – –
– +132.4% +149.6% +12.4% -41.2% -7.0% +225.2%
– +258.2% +409.3% +53.2% +31.4% -35.5% +32.1%
– +181.0% +70.5% +26.5% -10.8% +103.6% -17.4%
– – – – – – –
– – – – – – –
– – – – – – –
– – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?